Covidien Aims To Double Sales In Emerging Markets By 2017
This article was originally published in PharmAsia News
Executive Summary
Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm's Sept. 8 investor meeting in New York